Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia

Stem Cell Reports
C Ian SpencerBruce R Conklin

Abstract

Long-QT syndrome mutations can cause syncope and sudden death by prolonging the cardiac action potential (AP). Ion channels affected by mutations are various, and the influences of cellular calcium cycling on LQTS cardiac events are unknown. To better understand LQTS arrhythmias, we performed current-clamp and intracellular calcium ([Ca(2+)]i) measurements on cardiomyocytes differentiated from patient-derived induced pluripotent stem cells (iPS-CM). In myocytes carrying an LQT2 mutation (HERG-A422T), APs and [Ca(2+)]i transients were prolonged in parallel. APs were abbreviated by nifedipine exposure and further lengthened upon releasing intracellularly stored Ca(2+). Validating this model, control iPS-CM treated with HERG-blocking drugs recapitulated the LQT2 phenotype. In LQT3 iPS-CM, expressing NaV1.5-N406K, APs and [Ca(2+)]i transients were markedly prolonged. AP prolongation was sensitive to tetrodotoxin and to inhibiting Na(+)-Ca(2+) exchange. These results suggest that LQTS mutations act partly on cytosolic Ca(2+) cycling, potentially providing a basis for functionally targeted interventions regardless of the specific mutation site.

References

Dec 1, 1991·European Heart Journal·C T JanuaryJ C Makielski
Mar 1, 1991·Journal of Neuroscience Methods·J RaeM Watsky
Jul 1, 1984·American Heart Journal·L T Iseri, J H French
Feb 14, 1998·The Journal of Biological Chemistry·A E DoeringK D Philipson
Nov 24, 1999·Lancet·S Viskin
Mar 15, 2000·Journal of the American College of Cardiology·W Shimizu, C Antzelevitch
Jan 24, 2002·Nature·Eduardo Marbán
May 9, 2003·The New England Journal of Medicine·G Michael Vincent
Aug 23, 2003·American Journal of Physiology. Heart and Circulatory Physiology·C Ian Spencer, James S K Sham
Nov 18, 2003·The Journal of Physiology·Min WangJoshua R Berlin
Aug 3, 2005·The Journal of Clinical Investigation·Arthur J Moss, Robert S Kass
Aug 3, 2005·The Journal of Clinical Investigation·Dan M Roden, Prakash C Viswanathan
May 12, 2006·Journal of Cardiovascular Electrophysiology·Eric A SobieW J Lederer
Jan 11, 2007·Journal of Cardiovascular Electrophysiology·Donglin GuoGan-Xin Yan
Nov 7, 2008·Journal of Pharmacological Sciences·Kaichiro KamiyaMichael C Sanguinetti
Jul 14, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Lin WuLuiz Belardinelli
Dec 2, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jamal Nasir KhanJames Michael Glancy
Apr 8, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jiaoya XiFrank Pillekamp
Jul 3, 2010·Molecular Genetics and Metabolism·Nilesh J BokilKim M Summers
Oct 6, 2010·Journal of Molecular and Cellular Cardiology·Ihor ZahanichVictor A Maltsev
Jan 18, 2011·Nature·Ilanit ItzhakiLior Gepstein
Mar 25, 2011·Clinical Pharmacology and Therapeutics·H Inoue, S Yamanaka
Oct 26, 2011·The Journal of Physiology·Roshni V MadhvaniRiccardo Olcese
Nov 5, 2011·Disease Models & Mechanisms·Anna L LahtiKatriina Aalto-Setälä
Jun 28, 2012·Biophysical Journal·Marvin G ChangM Roselle Abraham
Jan 2, 2013·The Journal of General Physiology·Cecile TerrenoireRobert S Kass

❮ Previous
Next ❯

Citations

Feb 29, 2016·Cell Calcium·Todd J Herron
Mar 10, 2016·Biochimica Et Biophysica Acta·Juan C Del ÁlamoMark Mercola
Mar 15, 2016·Cell Stem Cell·Mohammad A MandegarBruce R Conklin
Oct 30, 2016·Journal of Pharmacological and Toxicological Methods·Kiyoshi TakasunaNorimasa Miyamoto
Sep 8, 2016·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Andrea BarbutiPatrizia Dell'Era
Mar 7, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yasunari KandaYuko Sekino
Dec 15, 2016·Scientific Reports·Ching-Hui WengYu-Feng Hu
Jul 25, 2017·BioResearch Open Access·Takaharu NegoroAkifumi Matsuyama
Sep 9, 2017·Disease Models & Mechanisms·Karina O BrandãoRichard P Davis
Jun 10, 2017·Circulation Research·Yoshinori Yoshida, Shinya Yamanaka
Jan 27, 2019·Expert Opinion on Biological Therapy·Wenbin LiangDarryl R Davis
Apr 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hua Rong LuDavid J Gallacher
May 23, 2019·Arrhythmia & Electrophysiology Review·Luca SalaPeter J Schwartz
Jul 4, 2020·Stem Cells Translational Medicine·Lila R Collins, Kelly A Shepard
Jun 25, 2020·International Journal of Molecular Sciences·Elvira Immacolata ParrottaGiovanni Cuda
Sep 10, 2020·Frontiers in Cell and Developmental Biology·Sayako HiroseTakeshi Kimura
Sep 12, 2020·Scientific Reports·Hannah L WatryLuke M Judge
May 21, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Stephane BedutFrancis Coge
Mar 25, 2017·Scientific Reports·Vassilios J BezzeridesAnthony Rosenzweig
Apr 17, 2018·Cellular and Molecular Bioengineering·Andrew P PetersenMegan L McCain
Jun 3, 2016·Cold Spring Harbor Protocols·Yuichiro MiyaokaBruce R Conklin
Oct 20, 2019·Cardiovascular Research·Matthew D PerryJamie I Vandenberg
Jun 3, 2017·Cellular and Molecular Life Sciences : CMLS·E GiacomelliM Bellin
Jan 1, 2016·Expert Opinion on Orphan Drugs·Lucie A Low, Danilo A Tagle
Aug 31, 2019·JACC. Basic to Translational Science·Lorenzo R SewananStuart G Campbell

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
pharmacotherapy
genetic modification
biopsy
biopsies

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.